Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
12/2007
12/05/2007EP1720848B1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007EP1272458B1 Arginine mimetics as factor xa inhibitors
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007CN101084207A Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/05/2007CN101084206A N-biaryl and n-arylheteroaryl 2-substituted piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
12/05/2007CN101084205A N-biaryl and n-arylheteroaryl piperazine derivatives as modulators of the 5ht2c receptor useful for the treatment of disorders related thereto
12/05/2007CN101084178A (benzyloxy-biphenyl) acetic acids and derivatives thereof
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/04/2007US7304174 CaSR antagonist
12/04/2007US7304165 Combination libraries
12/04/2007US7304094 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304065 Melanin concentrating hormone antagonists
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007CA2239313C Solid compound, its preparation and use in medicine
12/04/2007CA2185984C Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor
11/2007
11/29/2007WO2007137098A2 Sulfonyl-substituted bicyclic compounds as modulators of ppar
11/29/2007WO2007135106A1 Piperidine derivatives as human papilloma virus inhibitors
11/29/2007WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels
11/29/2007WO2007113249A3 N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
11/29/2007WO2007107385A3 Soluble adenylate cyclase inhibitors
11/29/2007WO2007078335A3 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070275979 Novel Compounds
11/29/2007US20070275965 CXCR4 modulators
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275932 Aryl, heteroaromatic and bicyclic aryl nitrone compounds, prodrugs and pharmaceutical compositions of the same to treat human disorders
11/29/2007CA2652469A1 Piperidine derivatives as human papilloma virus inhibitors
11/29/2007CA2651732A1 Intracellular kinase inhibitors
11/28/2007EP1858869A1 Acylated piperidines as glycine transporter inhibitors
11/28/2007EP1858868A1 Compounds
11/28/2007EP1858867A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof
11/28/2007EP1858866A1 Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine
11/28/2007EP1858865A1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
11/28/2007EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof
11/28/2007EP1654225A4 Melanin concentrating hormone receptor antagonists
11/28/2007EP0983222B1 Pharmaceutical agents for the treatment of cerebral amyloidosis
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN100351252C Novel process for the synthesis of carboxylic acid phenylamide
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007US7300934 carbocyclic carboxy nitriles such as 4-chloro-N-[2-({[(1S)-1-cyano-2-thien-3-ylethyl]amino}carbonyl)cyclohexyl]benzamide, used as cathepsin inhibitors; antimetastatic and antitumor agents; prophylaxis of cardiovascular and bone disorders
11/27/2007US7300797 Lysis reagent for blood cell analysis
11/27/2007CA2299710C Aryloxyaniline derivatives
11/22/2007WO2007131680A1 Insecticidal benzamidines
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2005117543A3 N-sulfonylcarboximidamide apoptosis promoters
11/22/2007US20070270437 Such as 5-{6-[(Methylsulfonyl)methyl]-1H-benzimidazol-1-yl}-3-({(1R)-1-[2-(trifluoromethyl)phenyl]-ethyl}oxy)-2-thiophenecarboxamide; for conditions associated with polo-like kinases
11/22/2007US20070270435 Novel Compounds
11/22/2007US20070270432 Novel Method
11/22/2007US20070270409 Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease
11/22/2007US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/22/2007US20070270389 Treating tetracycline resistant strains of Grampositive- or Gramnegative bacteria; antibiotics; [4S -(4a,5,5a,6,12a)]-4-(Dimethylamino)-9-[(-pyrrolidinocarbonyl)methyl]amino -1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
11/22/2007DE102005014080B4 Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel Addition salts of tolperisone, processes for their manufacture, use thereof and pharmaceutical compositions containing them
11/21/2007EP1856078A2 Process for the preparation of 1-aminopiperidine derivatives
11/21/2007EP1856077A1 Piperazine derivatives as glyt1 inhibitors
11/21/2007EP1856076A1 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
11/21/2007EP1856075A1 Substituted arylamine compounds and their use as 5-ht6 modulators
11/21/2007EP1856074A2 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
11/21/2007EP1856073A1 A PROCESS FOR THE PREPARATION OF AN 11-(4-SUBSTITUTED-I-PIPERAZINYL)DIBENZO[b,f][1,4]THIAZEPINE DERIVATIVE
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007EP1421062B1 Novel cyclohexyl sulphones
11/21/2007EP1417171B1 Multifunctional alkoxyamines based on polyalkylpiperidines, polyalkylpiperazinones and polyalkylmorpholinones and their use as polymerization regulators/initiators
11/21/2007CN101076524A Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
11/20/2007US7297817 Thio-substituted arylmethanesulfinyl derivatives
11/20/2007US7297794 Phenoxy amine compounds and compositions for delivering active agents
11/20/2007US7297793 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
11/20/2007US7297698 e.g. (2R,5S)-4-(3-chloro-4-cyanophenyl)-N-(2-cyclopropylpyrimidin-5-yl)-2,5-dimethylpiperazine-1-carboxamide; antiandrogenic agent
11/20/2007US7297697 4-(diarylmethyl)-1-piperazinyl derivatives
11/20/2007US7297289 For electrical storage devices, electrical double-layer capacitors, and secondary batteries
11/20/2007CA2206362C Substituted 1-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
11/15/2007WO2007128968A1 Telomerase inhibitors
11/15/2007WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007US20070265348 Therapeutic guanidines
11/15/2007US20070265270 Cinnoline derivatives as phosphodiesterase 10 inhibitors
11/15/2007US20070265269 Water Soluble Esters of [N-(4-Amino-2-Butynyl)] with Anticancer Activity
11/15/2007US20070265268 inhibiting heat shock protein 90 (Hsp90) family protein comprising administering benzoic acid derivatives or prodrugs, for the treatment of breast cancer or leukemia
11/15/2007US20070265258 Quinazoline derivatives as phosphodiesterase 10 inhibitors
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265241 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
11/14/2007EP1853578A1 Substituted tetralins as selective estrogen receptor-beta agonists
11/14/2007EP1853576A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
11/14/2007EP1853575A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
11/14/2007EP1853574A1 Process for making trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
11/14/2007EP1853565A1 Menthane carboxamide derivatives having cooling properties
11/14/2007CN101072765A Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites
11/14/2007CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007CN100348192C Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
11/13/2007US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007CA2345006C New benzoylguanidine derivatives with advantageous properties, processes for preparing them and their use in the production of pharmaceutical compositions
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/08/2007WO2007126362A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 341